Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Diffuse Intrinsic Pontine Glioma × Cilengitide × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Follicular 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Immunoblastic Lymphadenopathy 2 Hodgkin Disease 2 Gliosarcoma 2 Glioblastoma 2 Burkitt Lymphoma 2 Brain Neoplasms 2 Waldenstrom Macroglobulinemia 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Triple Negative Breast Neoplasms 1 Thrombocythemia, Essential 1 Sezary Syndrome 1 Sarcoma, Kaposi 1 Sarcoma 1 Renal Insufficiency 1 Primary Myelofibrosis 1 Precancerous Conditions 1 Polycythemia Vera 1 Optic Nerve Glioma 1 Oligodendroglioma 1 Neoplasms, Plasma Cell 1

Interventions

Radiotherapy 5 Radiation 3 Cyclophosphamide 3 ribociclib 2 Temozolomide 2 Panobinostat 2 Everolimus 2 Etoposide 2 Dasatinib 2 vandetanib 1 temsirolimus 1 pembrolizumab 1 ovex 1 marizomib 1 irinotecan sucrosofate 1 gallium maltolate 1 etoposide phosphate 1 crenolanib 1 adavosertib 1 abemaciclib 1 Vorinostat 1 Topotecan 1 TIC10 compound 1 Standard of Care 1 Specimen Handling 1 Sirolimus 1 Piperazine 1 Pharmacogenomic Variants 1 Pharmacogenomic Testing 1 PTC596 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01165333 2026-03-16

CILENT

Centre Oscar Lambret

Phase 1 Completed

Diffuse Intrinsic Pontine Glioma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡